6 completed, 2 active not recruiting, 1 suspended. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 6, Active not recruiting 2, Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Testosterone Propionate: new trials by email Literature Review of Testosterone Propionate trials Research Report on Testosterone Propionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer Biopsy, Bone Scan, Computed Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Active not recruiting | Roswell Park Cancer Institute | 3 | 2024-12-19 | 2026-08-07 |
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone Best Practice, Quality-of-Life Assessment, Questionnaire Administration - Hypogonadism, Malignant Urinary System Neoplasm | Phase 1 | Active not recruiting | Emory University | 56 | 2021-01-25 | 2026-05-26 |
| Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers. Bupropion, Anastrozole, Testosterone cyclopentylpropionate - Healthy Volunteers | Phase 1 | Completed | Parc de Salut Mar | 9 | 2020-12-03 | 2021-04-26 |
| Study of Testosterone and rHGH in FSHD Testosterone Enanthate, Somatropin - Facioscapulohumeral Muscular Dystrophy | Phase 1 | Completed | University of Rochester | 20 | 2017-12-18 | 2023-05-16 |
| A Study of Axiron® in Healthy Participants Axiron - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 12 | 2013-12-01 | 2014-08-19 |
| A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants Testosterone, Deodorant Spray, Deodorant and Antiperspirant Combination Spray - Healthy Participants | Phase 1 | Completed | Eli Lilly and Company | 30 | 2012-11-01 | 2014-10-16 |
| CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy Testosterone Cypionate - Hypogonadism | Phase 1 | Completed | VA Office of Research and Development | 105 | 2011-10-01 | 2019-03-05 |
| Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. Testosterone propionate - Vaginitis, Dyspareunia | Phase 1 / Phase 2 | Suspended | University of Vermont | 30 | 2006-12-01 | 2010-05-13 |
| Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy therapeutic testosterone - Prostate Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 2000-02-01 | 2013-01-18 |
Hypogonadism (2) · Prostatic Neoplasms (2) · Breast Neoplasms (1) · Dyspareunia (1) · Muscular Dystrophy, Facioscapulohumeral (1) · Urologic Diseases (1) · Urologic Neoplasms (1) · Vaginitis (1)
Eli Lilly and Company (2) · Emory University (1) · Memorial Sloan Kettering Cancer Center (1) · Parc de Salut Mar (1) · Roswell Park Cancer Institute (1) · University of Rochester (1) · University of Vermont (1) · VA Office of Research and Development (1)
United States (8) · Spain (1)
Ana M Aldea Perona, MD PhD (1) · Chad R Heatwole, MD, MS-CI (1) · Hyman Muss, MD (1) · Kenneth Ogan, MD (1) · Marie Wood, MD (1) · Michael Morris, MD (1) · Reina C Villareal, MD (1) · Sabrina M Witherby, MD (1) · Saby George, MD (1)
PMID 19375217, PMID 25123988, PMID 33735389, PMID 35027909, PMID 40900971
P01CA005826 (1), P30CA008748 (1), P30CA138292 (1)